Research Investigation
of Soy and Estrogen

More information about RISE

 

At menopause, women experience a dramatic drop in the production of the hormones estrogen and progesterone. Prescription hormone therapy contains estrogens, and women sometimes take prescription hormone therapy to treat some of the physical and psychological effects of these hormonal changes, including hot flashes, sleep disturbances, and mood alteration. Novasoy®400 is a soy-based dietary supplement that contains plant estrogens and is therefore called a phytoestrogen.

In many ways, a phytoestrogen acts similar to estrogen in the body. Many women are already using Novasoy®400 for the relief of menopausal symptoms like hot flashes. This product is commonly available through health food stores and can be obtained without a prescription.

Studies in women’s health do not provide a clear indication of whether soy improves hot flashes or not. We still do not know everything about the effects of phytoestrogens, such as soy, on hot flashes, mood, memory complaints, and anxiety and other menopausal symptoms in women.

The goal of RISE is to examine the effects of soy (NovaSoy®400) and estrogen on these menopausal symptoms in perimenopausal women. RISE is sponsored by the National Institute of Mental Health (NIMH).

For more information about study procedures click here.

 

woman.jpg

Are you bothered by hot flashes?

Can herbal supplements help?

If you are a healthy woman experiencing menopausal hot flashes, we invite you to take part in a research study to determine if soy – a popular herbal supplement – can help ease menopausal symptoms.

 

logo rise Research Investigation of Soy and Estrogen

 

You might be eligible to take part in a research study to determine if soy can help ease symptoms of menopause.

 

Who can join?

  • Healthy women aged 40 to 65
  • Experiencing hot flashes
  • Have not had a hysterectomy
  • Non-smoker

Participants will receive a $200 stipend for time and expenses.

For more information, contact the University of Illinois at Chicago at 312-355-5652 or UIC.RISE.study@gmail.com

 

This study is funded by the National Institutes of Health, the Primary Federal agency for conducting and supporting basic, clinical and translational medical research; Principal Investigator: Pauline M. Maki, Ph.D.

 

Home |  RISE Home |  About RISE |  FAQ |  Participating in RISE |  Research Staff |  Related Links |  Other Research |  Contact Us |